Last update 08 May 2025

Trafermin biosimilar (Translational Research Informatics Center)

Overview

Basic Info

Drug Type
Biosimilar, Growth factors
Synonyms
FGF-2, Trafermin, bFGF
+ [5]
Target
FGFRs
Action
stimulants
Mechanism
FGFRs stimulants(Fibroblast growth factor receptors stimulants)
Therapeutic Areas
Otorhinolaryngologic DiseasesOther Diseases
Active Indication
Tympanic Membrane Perforation
Inactive Indication-
Originator Organization
Translational Research Informatics Center
Active Organization
Nobelpharma Co., Ltd.Nobelpharma Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
Japan (20 Sep 2019),
Tympanic Membrane Perforation
Regulation-
Login to view timeline

Structure/Sequence

Related

2
Clinical Trials associated with Trafermin biosimilar (Translational Research Informatics Center)
JPRN-jRCT2051230028
/ RecruitingPhase 3IIT
Regenerative Therapy for Soft Tissue Defects of the External Auditory Meatus with NPC-18
JPRN-UMIN000017622
/ CompletedPhase 3IIT
A Phase III study on the regenerative treatment of tympanic membrane with NPC-18 and FBG-18-multicenter,investigator initiated clinical trial. - A Phase III study on the regenerative treatment of tympanic membrane with NPC-18 and FBG-18-multicenter,investigator initiated clinical trial.
100 Clinical Results associated with Trafermin biosimilar (Translational Research Informatics Center)
Login to view more data
100 Translational Medicine associated with Trafermin biosimilar (Translational Research Informatics Center)
Login to view more data
100 Patents (Medical) associated with Trafermin biosimilar (Translational Research Informatics Center)
Login to view more data
100 Deals associated with Trafermin biosimilar (Translational Research Informatics Center)
Login to view more data

External Link

KEGGWikiATCDrug Bank
D03362--
DB06244

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Tympanic Membrane Perforation
Japan
Nobelpharma Co., Ltd.Nobelpharma Co., Ltd.
20 Sep 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free